• Latest

Daily pill halts pancreatic cancer growth in major clinical breakthrough

November 20, 2026

Mexican Special Forces Capture Top Cartel Boss ‘El Chapo Isidro’ in Sinaloa Raid

November 21, 2026

Rescue operations after drones strike Russian cargo ship in Gulf of Finland

November 21, 2026

UN-backed talks on autonomous weapons end without agreement on new treaty

November 21, 2026

Oil Prices Settle Into New Normal Amid Surplus and Geopolitical Risks

November 21, 2026

COP31 climate talks deadlocked as fossil fuel dispute pushes summit into overtime

November 21, 2026

Brazil’s ex-president Jair Bolsonaro hospitalized with severe abdominal pain

November 21, 2026

Denmark Expels Russian Diplomat Over Alleged Plot to Kill Ukrainian Rapper

November 21, 2026

Russian missile lands in Poland during NATO drills, prompting condemnation

November 21, 2026

‘Hunger Games: Sunrise on the Reaping’ Scores $21M+ in Previews, Eyes $100M+ Debut

November 20, 2026

UK Agrees to 100,000 EU Youth Visas in Major Mobility Deal at Brussels Summit

November 20, 2026

White House names Kirsten Davies as national cyber director after mass outages

November 20, 2026

US Senate Rejects Resolution to Limit Trump’s Military Actions in Iran

November 20, 2026
Picupnews
  • Home
  • World
  • Politics
  • Economy
  • Tech
  • Science
  • Lifestyle
  • Entertainment
  • Sports
  • Contact
No Result
View All Result
  • Home
  • World
  • Politics
  • Economy
  • Tech
  • Science
  • Lifestyle
  • Entertainment
  • Sports
  • Contact
No Result
View All Result
No Result
View All Result
Picupnews
  • Home
  • World
  • Politics
  • Economy
  • Tech
  • Science
  • Lifestyle
  • Entertainment
  • Sports
  • Contact
Home Latest

Daily pill halts pancreatic cancer growth in major clinical breakthrough

Picupnews Newsroom by Picupnews Newsroom
November 20, 2026
in Latest, Lifestyle
Share on TwitterShare on Facebook

A daily pill used alongside chemotherapy has halted the growth of pancreatic tumours in the vast majority of patients in a new clinical trial, in what experts are calling the most significant advance in pancreatic cancer treatment in decades. The drug, daraxonrasib, has shown the potential to shrink or even eliminate tumours in some cases, offering fresh hope against one of the most lethal forms of cancer.

According to trial results presented by Dr. Wungki Park of Memorial Sloan Kettering Cancer Center, tumours stopped growing in 90% of the 61 participants with advanced pancreatic cancer who received daraxonrasib in combination with standard chemotherapy. More than 60% of patients saw their tumours shrink or disappear, and in one in 12 patients, no cancer was detectable on CT scans following treatment.

Dr. Park described the findings as unprecedented, stating, “This is the closest to cure,” after observing tumours vanish in patients whose cancer had already spread to other organs. Cancer Research UK echoed this sentiment, calling the results “the biggest leap forward we’ve seen in decades for pancreatic cancer patients.”

The trial focused on patients recently diagnosed with advanced pancreatic cancer, a disease often referred to as a “silent killer” due to its subtle symptoms and rapid progression. Pancreatic cancer has the lowest survival rate among common cancers in the UK, with half of all patients dying within three months of diagnosis and only about 3% surviving for five years if the cancer has metastasized.

Daraxonrasib, also known as Rasonque, is a pan-RAS inhibitor designed to target a key driver of tumour growth. The drug’s objective response rate in the trial reached nearly 61%, including 8% of patients achieving a complete response, meaning their tumours were no longer detectable. The disease control rate—patients whose cancer stopped growing or shrank—exceeded 90%, according to updated data presented at the EORTC-NCI-AACR Symposium in Barcelona.

Experts not involved in the study, such as Professor Shivan Sivakumar of the University of Birmingham, highlighted the potential of daraxonrasib to move pancreatic cancer treatment beyond chemotherapy, which has long been the mainstay despite limited effectiveness. “What is particularly exciting is the potential to move beyond chemotherapy as the mainstay of treatment for pancreatic cancer,” Sivakumar said.

Michelle Mitchell, chief executive of Cancer Research UK, said the pill represents a “massive hope” for patients facing a disease with few effective options. The charity emphasised the urgent need for new treatments, given the poor prognosis and late detection associated with pancreatic cancer.

Despite the encouraging results, researchers caution that the findings are still early and based on a relatively small group of patients. Further studies are needed to confirm the long-term benefits and to determine whether these outcomes can be replicated in larger, more diverse populations. The availability of the pill for wider use will depend on the results of ongoing and future clinical trials.

Why it matters

The emergence of daraxonrasib as a potential new standard in pancreatic cancer treatment marks a significant shift for patients and clinicians. Pancreatic cancer has long been one of the deadliest cancers, with survival rates lagging far behind those for other common cancers. According to Cancer Research UK, the disease has seen little progress in outcomes for decades, making these new results particularly significant.

For patients, the prospect of a daily pill that can stop tumour growth and, in some cases, make cancer undetectable, offers hope where few options previously existed. Dr. Wungki Park’s statement that this is “the closest to cure” underscores the scale of the advance, especially for those with advanced or metastatic disease who typically face a grim prognosis.

The trial’s success also signals potential changes for future research and treatment approaches. As Professor Sivakumar highlighted, the ability to move beyond chemotherapy could pave the way for combination therapies and more targeted interventions. With further trials planned and ongoing, the oncology community will be watching closely to see if daraxonrasib can deliver lasting improvements in survival and quality of life for pancreatic cancer patients worldwide.

The image accompanying this article is an AI-generated illustrative depiction inspired by the actual scene of the event.

Tags: Cancer Research UKclinical trialsdaraxonrasibpancreatic cancerWungki Park
Previous Post

‘Hunger Games: Sunrise on the Reaping’ Scores $21M+ in Previews, Eyes $100M+ Debut

Next Post

Russian missile lands in Poland during NATO drills, prompting condemnation

Related Posts

Mexican Special Forces Capture Top Cartel Boss ‘El Chapo Isidro’ in Sinaloa Raid

November 21, 2026

Mexican special forces have captured Fausto Isidro Meza Flores, known as 'El Chapo Isidro', in a major overnight operation in...

Rescue operations after drones strike Russian cargo ship in Gulf of Finland

November 21, 2026

Rescue efforts are under way in the Gulf of Finland after a Russian cargo ship was struck by drones and...

UN-backed talks on autonomous weapons end without agreement on new treaty

November 21, 2026

Efforts to establish international rules on the use of lethal autonomous weapons collapsed in Geneva this week, as United Nations-backed...

Oil Prices Settle Into New Normal Amid Surplus and Geopolitical Risks

November 21, 2026

Global oil prices are stabilizing at higher levels as traders and analysts reach a consensus that the market has entered...

COP31 climate talks deadlocked as fossil fuel dispute pushes summit into overtime

November 21, 2026

Negotiations at the COP31 UN climate summit in Antalya, Turkey, have reached a deadlock, with nearly 200 countries unable to...

Brazil’s ex-president Jair Bolsonaro hospitalized with severe abdominal pain

November 21, 2026

Former Brazilian president Jair Bolsonaro was hospitalized in Brasília on Friday after experiencing severe abdominal pain and distension, according to...

Next Post

Russian missile lands in Poland during NATO drills, prompting condemnation

  • Trending
  • Comments
  • Latest

BlackRock’s Rick Rieder Seizes AI Debt Boom Amid Record Tech Bond Issuance

November 19, 2026

Stock futures surge as oil prices fall and tech shares rebound ahead of US midterms

November 2, 2026

Global Timekeepers Move Toward Redefining the Second and Replacing Leap Second

November 17, 2026

Trip.com Launches ‘My Travel Impact’ as Majority of Travellers Prioritise Sustainability

November 19, 2026

Japan’s Groundbreaking Martian Moon Mission Set to Launch Tomorrow

Pope Leo XIV Steps Back onto World Stage Day after Hospital Discharge

World Bank Advocates ‘Small AI’ for Rapid Development in Emerging Economies

Microsoft Abandons Major AI Data Centre Project in Essex Amidst Power Supply Dilemmas

Mexican Special Forces Capture Top Cartel Boss ‘El Chapo Isidro’ in Sinaloa Raid

November 21, 2026

Rescue operations after drones strike Russian cargo ship in Gulf of Finland

November 21, 2026

UN-backed talks on autonomous weapons end without agreement on new treaty

November 21, 2026

Oil Prices Settle Into New Normal Amid Surplus and Geopolitical Risks

November 21, 2026

Recent News

Mexican Special Forces Capture Top Cartel Boss ‘El Chapo Isidro’ in Sinaloa Raid

November 21, 2026

Rescue operations after drones strike Russian cargo ship in Gulf of Finland

November 21, 2026

UN-backed talks on autonomous weapons end without agreement on new treaty

November 21, 2026

Oil Prices Settle Into New Normal Amid Surplus and Geopolitical Risks

November 21, 2026
Picupnews

As a next-generation news agency, we are here to deliver the most important summaries from the global agenda quickly and impartially. Follow us for the latest updates and stay connected to the news!

Follow Us

Get the Picupnews app

▶ Google Play App Store

Browse by Category

  • Economy & Business
  • Entertainment
  • Latest
  • Lifestyle
  • News
  • Politics
  • Science
  • Sports
  • Tech
  • World

Recent News

Mexican Special Forces Capture Top Cartel Boss ‘El Chapo Isidro’ in Sinaloa Raid

November 21, 2026

Rescue operations after drones strike Russian cargo ship in Gulf of Finland

November 21, 2026
  • Privacy & Policy
  • Türkçe
  • Contact
  • About
  • Terms of Use

© 2026 Picupnews. All rights reserved. · About · Privacy and Cookie Policy · Contact

  • Contact
No Result
View All Result

© 2026 Picupnews. All rights reserved. · About · Privacy and Cookie Policy · Contact

This website uses cookies to analyse traffic and to show ads. By continuing to use the site, you agree to our use of cookies. Privacy and Cookie Policy
This content is powered by n8n automation. Build your own: Educattech  ·  AI content platform: Ommini